We are live on
!
Find out more
WIM
Woodford Investment Management Portfolio holdings
AUM
$310M
1-Year Est. Return
17.41%
This Fund
S&P 500
This Quarter
Est. Return
+11.15%
1 Year Est. Return
-17.41%
3 Year Est. Return
-27.14%
5 Year Est. Return
+68.29%
10 Year Est. Return
–
AUM
$466M
AUM Growth
–
Cap. Flow
+$252M
Cap. Flow
% of AUM
53.97%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
4
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alkermes
ALKS
|
+$101M |
| 2 |
Prothena Corp
PRTA
|
+$67.6M |
| 3 |
BHBK
Blue Hills Bancorp, Inc.
BHBK
|
+$48.8M |
| 4 |
NWBO
Northwest Biotherapeutics, Inc. Common stock
NWBO
|
+$34.6M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 50.51% |
| 2 | Healthcare | 49.49% |
Similar funds
LCM
GWA
NC
IPC
AEPG
AR
KCM
COI
Woodford Investment Management's Q4 2014 Portfolio in Review
Q4 2014 is the first quarter with a 13F filing on record for Woodford Investment Management, which disclosed 4 positions worth $466M. Its ten largest holdings account for 100% of the portfolio.
Its largest position is Alkermes: 1,975,057 shares worth $125M.
By sector, the portfolio is most concentrated in Financials at 51% of assets, followed by Healthcare.
- Woodford Investment Management's largest Q4 2014 buy was Alkermes: 1,975,057 shares worth $125M.
- Woodford Investment Management's ten largest holdings make up 100% of its $466M portfolio in Q4 2014.
- Woodford Investment Management disclosed 4 positions in Q4 2014, its first 13F filing on record.
Based on Woodford Investment Management's 13F filing for Q4 2014, filed 6 Apr 2015.